Home/News/Market context Source: Investing.com ↗ Citizens reiterates Structure Therapeutics stock rating on trial data Published Sep 09, 2026 09:10 UTC | Translation unavailable. Please try again. Original report Read the original report on Investing.com ↗ Recommended marketsNo specific asset was identified in this report; browse live USDT reference pairs.Browse markets → BTC/USDT $67,315.00 -4.44% USDC/USDT $1.00 -0.02% ETH/USDT $1,897.51 -5.04% SOL/USDT $75.50 -6.40% ZEC/USDT $923.34 -3.04%